Ameritas Investment Partners, Inc. - AKERO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$260,234
+50.2%
5,145
+38.7%
0.01%
+42.9%
Q2 2023$173,220
+62.3%
3,710
+33.0%
0.01%
+75.0%
Q1 2023$106,745
-18.6%
2,7900.0%0.00%
-20.0%
Q4 2022$131,130
+92.8%
2,790
+38.4%
0.01%
+66.7%
Q3 2022$68,000
+257.9%
2,0160.0%0.00%
+200.0%
Q2 2022$19,000
-34.5%
2,0160.0%0.00%0.0%
Q1 2022$29,000
-32.6%
2,0160.0%0.00%0.0%
Q4 2021$43,000
-4.4%
2,0160.0%0.00%
-50.0%
Q3 2021$45,000
-10.0%
2,0160.0%0.00%0.0%
Q2 2021$50,000
+78.6%
2,016
+107.8%
0.00%
+100.0%
Q1 2021$28,000
+12.0%
9700.0%0.00%0.0%
Q4 2020$25,000
-16.7%
9700.0%0.00%0.0%
Q3 2020$30,000
+66.7%
970
+32.9%
0.00%0.0%
Q2 2020$18,000
+125.0%
730
+82.5%
0.00%–
Q1 2020$8,000
-11.1%
4000.0%0.00%–
Q4 2019$9,0000.0%4000.0%0.00%–
Q3 2019$9,000–400–0.00%–
 Download
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Skorpios Trust 1,621,829$75,723,19632.88%
COMMODORE CAPITAL LP 1,675,000$78,205,7508.79%
Ghost Tree Capital, LLC 360,000$16,808,4005.55%
Boxer Capital, LLC 1,676,733$78,2873.63%
SILVERARC CAPITAL MANAGEMENT, LLC 241,357$11,268,9583.49%
Atlas Venture Life Science Advisors, LLC 594,251$27,745,5793.45%
SILVERARC CAPITAL MANAGEMENT, LLC 236,500$11,039,8203.42%
Logos Global Management LP 520,000$24,278,8003.30%
Redmile Group, LLC 1,811,672$84,586,9663.25%
Yiheng Capital Management, L.P. 1,201,591$56,102,2843.03%
View complete list of AKERO THERAPEUTICS INC shareholders